Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: obesity

Are ANAs More Prevalent in the U.S. Now Than in the Past?

Arthritis & Rheumatology  |  May 28, 2020

According to a new study, the prevalence of anti-nuclear antibodies (ANAs), the most common biomarker of autoimmunity in the U.S., has increased considerably in recent years among adolescents aged 12–19 years, in both sexes (especially in men), older adults (age ≥50 years) and non-Hispanic whites…

Filed under:ConditionsResearch Rheum Tagged with:ANA testanti-nuclear antibodiesArthritis & RheumatologyResearch

Seronegative RA May Be on the Rise

Carina Stanton  |  May 25, 2020

A study comparing trends in the incidence of RA from 2005 to 2014 with previous decades showed a shift in RA subset, suggesting the need for timely recognition of rheumatoid factor-negative RA…

Filed under:ConditionsRheumatoid Arthritis Tagged with:2019 ACR/ARP Annual MeetingRheumatoid Arthritis (RA)seronegative RAtrends

Autoimmunity on the Rise in the U.S.

Marilynn Larkin  |  April 21, 2020

NEW YORK (Reuters Health)—The prevalence of antinuclear antibodies (ANA) in the blood of U.S. adolescents and adults has increased over the past 30 years, signaling a rise in autoimmunity, researchers say. “It is not known if these same increases are occurring in other parts of the world, but because ANA are associated with many autoimmune…

Filed under:ConditionsResearch Rheum Tagged with:antinuclear antibodiesArthritis & RheumatologyAutoimmuneautoimmunity

New Study Identifies How Big a Role Diet Plays in Hyperuricemia

Elizabeth Hofheinz, MPH, MEd  |  April 15, 2020

Living like a king has its price. And while kings and queens are primarily something of yesteryear, the vast majority of those living in reasonably wealthy nations can now live like kings. Now, back to that price. Gout, once known as the disease of kings, has been around at least since the time of the…

Filed under:ConditionsGout and Crystalline ArthritisResearch Rheum Tagged with:AlcoholDietGouthyperuricemia

Do You Know Your Legal Obligations to Disabled Patients?

Kurt Ullman  |  April 13, 2020

The Americans with Disabilities Act (ADA) was passed in 1990 to protect the civil rights of people with disabilities. This law, and amendments passed in 2008, resulted in rules and regulations opening access to private settings serving the public, including doctors’ offices and medical facilities. The ADA includes a three-pronged definition of disability. If any…

Filed under:Legal UpdatesPatient Perspective Tagged with:Americans with Disabilities Act

A Public Health Approach to Arthritis

Thomas R. Collins  |  March 12, 2020

ATLANTA—Rheumatic diseases have been the subject of a range of public health campaigns and reports over the past decade, but improving their visibility remains a work in progress, a Centers for Disease Control and Prevention (CDC) expert said at the 2019 ACR/ARP Annual Meeting. A growing attention to pain and the opioid crisis may help…

Filed under:AnalgesicsConditionsMeeting Reports Tagged with:2019 ACR/ARP Annual MeetingCenters for Disease Control and Preventionopioid crisisPain Managementpublic health

Can Lupus Be Prevented? Research Reveals Clues to Who’s Most Likely to Transition to Classified Disease

Susan Bernstein  |  February 25, 2020

How does a patient transition from health to active SLE? This question is the crux of the research conducted by Judith A. James, MD, PhD, and colleagues…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:2019 ACR/ARP Annual Meetingenvironmental factorgeneticSLEsystemic lupus erythematosus (SLE)

A Public Health Approach to Arthritis: Experts Continue to Raise Awareness of Arthritis Burden

Thomas R. Collins  |  February 12, 2020

Public health agencies have been raising the profile of arthritis…

Filed under:Professional Topics Tagged with:ArthritisburdenCDCpublic health

The 2019 ACR Award Winners & Distinguished Fellows

Carol Patton  |  December 18, 2019

ATLANTA—Every year at its Annual Meeting, the ACR recognizes its members’ outstanding contributions to the field of rheumatology through an awards program. The ACR is proud to announce 20 award recipients for 2019, honored for their accomplishments as clinicians, instructors or researchers who have helped advance rheumatology, for their commitment to inspire others to enter…

Filed under:AwardsFrom the CollegeProfessional Topics Tagged with:2019 ACR/ARP Annual MeetingDr. Alfred E. DenioDr. Ali Duarte-GarciaDr. Amr H. SawalhaDr. Brian NolanDr. Bruce CronsteinDr. Dana DiRenzoDr. J. Timothy HarringtonDr. Jean LiewDr. John P. AtkinsonDr. Katherine P. LiaoDr. Marcy B. BolsterDr. Mazen NasrallahDr. Michael A. PaleyDr. Natalie RosenwasserDr. Patricia KatzDr. Polly FergusonDr. Rebecca HabermanDr. Sarah ChenDr. Susan ManziJonathan TL Cheah

Hriana / shutterstock.com

ACR Publishes Disease Activity and Functional Status Assessment Measure Recommendations for RA

Mary Beth Nierengarten  |  December 10, 2019

The recommendations include updated disease activity measures and a new set of functional status assessment measures for rheumatoid arthritis.

Filed under:Clinical Criteria/GuidelinesRheumatoid Arthritis Tagged with:disease activity measuresDr. Bryant EnglandDr. Claire BarberDr. Kaleb Michaudfunctional status assessment measuresrecommendations

  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 26
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences